Xiaomeng Tang

1.3k total citations
38 papers, 945 citations indexed

About

Xiaomeng Tang is a scholar working on Molecular Biology, Immunology and Pharmaceutical Science. According to data from OpenAlex, Xiaomeng Tang has authored 38 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Pharmaceutical Science. Recurrent topics in Xiaomeng Tang's work include Advancements in Transdermal Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (4 papers) and Extracellular vesicles in disease (4 papers). Xiaomeng Tang is often cited by papers focused on Advancements in Transdermal Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (4 papers) and Extracellular vesicles in disease (4 papers). Xiaomeng Tang collaborates with scholars based in China, United States and Uganda. Xiaomeng Tang's co-authors include Jiyong Liu, Yongwei Gu, Meng Yang, Aixue Li, Ting Wang, Liangdi Jiang, Yue Du, Yunan Zhao, Welley Siu Loc and Mark Kester and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Functional Materials and ACS Applied Materials & Interfaces.

In The Last Decade

Xiaomeng Tang

36 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaomeng Tang China 18 392 230 196 182 108 38 945
Donghang Xu China 17 449 1.1× 124 0.5× 216 1.1× 226 1.2× 104 1.0× 54 995
Marwa A. Sallam Egypt 19 350 0.9× 283 1.2× 251 1.3× 186 1.0× 145 1.3× 34 1.0k
Sanket Shah India 9 367 0.9× 247 1.1× 287 1.5× 210 1.2× 88 0.8× 16 884
Xiaojun Shi China 16 297 0.8× 115 0.5× 170 0.9× 118 0.6× 66 0.6× 40 947
Tanweer Haider India 18 316 0.8× 147 0.6× 204 1.0× 143 0.8× 53 0.5× 36 867
Prarthana Rewatkar Australia 16 364 0.9× 144 0.6× 191 1.0× 147 0.8× 64 0.6× 23 867
Yub Raj Neupane Singapore 20 520 1.3× 379 1.6× 290 1.5× 138 0.8× 62 0.6× 42 1.2k
Mingzhu Lei China 18 440 1.1× 122 0.5× 82 0.4× 146 0.8× 113 1.0× 31 957
Felisa Cilurzo Italy 21 496 1.3× 434 1.9× 340 1.7× 216 1.2× 79 0.7× 35 1.3k
Benedetta Ferrara Italy 17 314 0.8× 152 0.7× 222 1.1× 157 0.9× 98 0.9× 27 765

Countries citing papers authored by Xiaomeng Tang

Since Specialization
Citations

This map shows the geographic impact of Xiaomeng Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomeng Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomeng Tang more than expected).

Fields of papers citing papers by Xiaomeng Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaomeng Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomeng Tang. The network helps show where Xiaomeng Tang may publish in the future.

Co-authorship network of co-authors of Xiaomeng Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomeng Tang. A scholar is included among the top collaborators of Xiaomeng Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomeng Tang. Xiaomeng Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Cai, Huanhuan, Aixue Li, Xiaomeng Tang, et al.. (2024). Application of biodegradable microsphere injections: an anticancer perspective. Materials Advances. 5(8). 3094–3112. 7 indexed citations
3.
Miao, Huijie, Xiaomeng Tang, Yun Cui, et al.. (2024). Obeticholic Acid Inhibit Mitochondria Dysfunction Via Regulating ERK1/2‐DRP Pathway to Exert Protective Effect on Lipopolysaccharide‐Induced Myocardial Injury. Advanced Biology. 8(7). e2300576–e2300576. 3 indexed citations
4.
Tang, Xiaomeng, Liang Chen, Jinlong Tian, et al.. (2024). Antibacterial Activity of Plants in Cirsium: A Comprehensive Review. Chinese Journal of Integrative Medicine. 30(9). 835–841. 4 indexed citations
6.
Li, Aixue, Dan Li, Yongwei Gu, et al.. (2023). Plant-derived nanovesicles: Further exploration of biomedical function and application potential. Acta Pharmaceutica Sinica B. 13(8). 3300–3320. 65 indexed citations
7.
Zhao, Yunan, Yongwei Gu, Qi Fu, et al.. (2023). Engineering adipocytes for targeting delivery of triptolide derivative and Ce6 for malignant melanoma cytotoxic-PDT synergistic strategy. Materials & Design. 228. 111860–111860. 13 indexed citations
9.
Liu, Tiantian, Zhenliang Wen, Yun Cui, et al.. (2023). ATF4 knockdown in macrophage impairs glycolysis and mediates immune tolerance by targeting HK2 and HIF-1α ubiquitination in sepsis. Clinical Immunology. 254. 109698–109698. 31 indexed citations
10.
Meng, Huan, Shuang Wang, Xiaomeng Tang, et al.. (2022). Respiratory immune status and microbiome in recovered COVID-19 patients revealed by metatranscriptomic analyses. Frontiers in Cellular and Infection Microbiology. 12. 1011672–1011672. 3 indexed citations
11.
Tang, Xiaomeng, Dan Li, Yongwei Gu, et al.. (2022). Natural cell based biomimetic cellular transformers for targeted therapy of digestive system cancer. Theranostics. 12(16). 7080–7107. 12 indexed citations
12.
Gu, Yongwei, Yue Du, Liangdi Jiang, et al.. (2022). αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma. Journal of Nanobiotechnology. 20(1). 384–384. 51 indexed citations
13.
Ma, Chao, et al.. (2022). Anti-cervical cancer effects of Compound Yangshe granule through the PI3K/AKT pathway based on network pharmacology. Journal of Ethnopharmacology. 301. 115820–115820. 17 indexed citations
14.
Jiang, Liangdi, Yongwei Gu, Yue Du, et al.. (2021). Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy. ACS Applied Materials & Interfaces. 13(36). 42411–42428. 65 indexed citations
15.
Tang, Xiaomeng, Meng Yang, Yongwei Gu, et al.. (2021). Orally Deliverable Dual-Targeted Pellets for the Synergistic Treatment of Ulcerative Colitis. Drug Design Development and Therapy. Volume 15. 4105–4123. 11 indexed citations
16.
Yang, Qing, Shanshan Liu, Yongwei Gu, et al.. (2019). <p>Development of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity</p>. International Journal of Nanomedicine. Volume 14. 3955–3966. 33 indexed citations
17.
Gu, Yongwei, Meng Yang, Xiaomeng Tang, et al.. (2018). Lipid nanoparticles loading triptolide for transdermal delivery: mechanisms of penetration enhancement and transport properties. Journal of Nanobiotechnology. 16(1). 68–68. 62 indexed citations
18.
Loc, Welley Siu, Gail L. Matters, Christopher O. McGovern, et al.. (2017). Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancer. Nanomedicine Nanotechnology Biology and Medicine. 13(7). 2313–2324. 12 indexed citations
20.
Yin, Tingjie, Ying Zhang, Yanhong Liu, et al.. (2017). The efficiency and mechanism of N-octyl-O, N-carboxymethyl chitosan-based micelles to enhance the oral absorption of silybin. International Journal of Pharmaceutics. 536(1). 231–240. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026